The Enterprise Value as of November 2025 (TTM) for GreenLight Biosciences Holdings (GRNA) is 57.81M

According to GreenLight Biosciences Holdings’s latest financial reports and current stock price. The company's current Enterprise Value is 57.81M. This represents a change of -70.82% compared to the average of 198.13M of the last 4 quarters.

GreenLight Biosciences Holdings (GRNA) Historical Enterprise Value (quarterly & annually)

How has GRNA Enterprise Value performed in the past?

The mean historical Enterprise Value of GreenLight Biosciences Holdings over the last ten years is 802.28M. The current 57.81M Enterprise Value has changed 620.62% with respect to the historical average. Over the past ten years (40 quarters), GRNA's Enterprise Value was at its highest in in the December 2021 quarter at 1.17B. The Enterprise Value was at its lowest in in the March 2023 quarter at 110.63M.

GreenLight Biosciences Holdings (GRNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GreenLight Biosciences Holdings Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GreenLight Biosciences Holdings (GRNA) Average Enterprise Value

How has GRNA Enterprise Value performed in the past?

The current Enterprise Value of GreenLight Biosciences Holdings (GRNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GreenLight Biosciences Holdings (GRNA) Enterprise Value vs. Peers

How is GRNA’s Enterprise Value compared to its peers?

GreenLight Biosciences Holdings’s Enterprise Value is greater than Lunai Bioworks Inc. (35.00M), less than bluebird bio, Inc. (158.07M), less than Spyre Therapeutics, Inc. (1.97B), greater than Rein Therapeutics Inc. (31.90M), greater than Magenta Therapeutics, Inc. (-12257976.00), less than AlloVir, Inc. (69.87M), greater than Pluristem Therapeutics Inc. (43.29M), greater than ERYTECH Pharma S.A. (3.80M), greater than LianBio (-40025352.00), greater than Satsuma Pharmaceuticals, Inc. (20.18M),

Build a custom stock screener for GreenLight Biosciences Holdings (GRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GreenLight Biosciences Holdings using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GreenLight Biosciences Holdings (GRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GreenLight Biosciences Holdings or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.